The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Orafluke 10 % w/v Oral Suspension

100, 100 milligram(s)/millilitre Oral suspension

Interchem Ireland LtdVPA10555/003/002

Main Information

Trade NameOrafluke 10 % w/v Oral Suspension
Active SubstancesFenbendazole
Strength100, 100 milligram(s)/millilitre
Dosage FormOral suspension
Licence HolderInterchem Ireland Ltd
Licence NumberVPA10555/003/002

Group Information

ATC CodeQP52AC13 fenbendazole
Therapeutic ClassEndoparasiticide


Licence Issued18/04/2008
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back